Prevalence and factors of COVID-19 vaccine refusal among solid cancer patients in China: an application of the health belief model
Open Access
- 3 August 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1236376
Abstract
Introduction: It is essential to protect cancer patients from contracting COVID-19 through vaccination. A majority of cancer patients are recommended by international health authorities to take up the vaccines. COVID-19 vaccine refusal among cancer patients during the pandemic period is under-researched. This study investigated factors of vaccine refusal based on the Health Belief Model (HBM).Methods: A cross-sectional study was conducted among female breast cancer patients, male/female thyroid cancer patients, and gynecological cancer patients in Shantou, China from April to August 2022 (n = 1,115). Multinomial logistic regression analysis adjusted for socio-demographics was conducted to test factors of COVID-19. Adjusted odds ratios of the two models comparing vaccine refusal vs. “vaccine non-refusal” and vaccine refusal vs. ever-vaccination were derived and presented.Results: Of all the participants, the prevalence of vaccine refusal, “vaccine non-refusal,” and ever-vaccination was 25.9, 22.2, and 51.8%, respectively. In both multinomial logistic regression models, significant factors of vaccine refusal included socio-demographics (age, education level, employment status, monthly household income, cancer type, duration since cancer diagnosis, current treatment status) and some vaccine-related HBM (perceived benefits, perceived barriers, cue to action, and self-efficacy). Perceived severity of COVID-19 was significant only in the vaccine refusal vs. ever-vaccination model. In neither model, perceived susceptibility to contract COVID-19 was statistically significant.Conclusion: About ¼ of the participants expressed vaccine refusal. Interventions are warranted. Future longitudinal studies are needed to verify this study’s findings. Pilot interventions should also be launched to test effectiveness of interventions modifying the significant HBM factors found in this study.Keywords
This publication has 78 references indexed in Scilit:
- Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient DataJCO Global Oncology, 2020
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyThe Lancet, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakCancer Discovery, 2020
- Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysisAging, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Vaccines Through Centuries: Major Cornerstones of Global HealthFrontiers in Public Health, 2015
- Beliefs and attitudes regarding human papillomavirus vaccination among college-age womenJournal of Health Psychology, 2012
- How Experience Shapes Health BeliefsHealth Education & Behavior, 2012
- The Role of Behavioral Science Theory in Development and Implementation of Public Health InterventionsAnnual Review of Public Health, 2010